Trial · NCT03971422
Results by group27
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 27
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline to Day 43 in Myasthenia Gravis-Activities of Daily Living (MG-ADL) Score | Placebo | -0.784 | Standard Error 0.488 | units on a scale | |
| Change From Baseline to Day 43 in Myasthenia Gravis-Activities of Daily Living (MG-ADL) Score | Rozanolixizumab ~7 mg/kg | -3.370 | Standard Error 0.486 | units on a scale | |
| Change From Baseline to Day 43 in Myasthenia Gravis-Activities of Daily Living (MG-ADL) Score | Rozanolixizumab ~10 mg/kg | -3.403 | Standard Error 0.494 | units on a scale | |
| Percentage of Participants Achieving Myasthenia Gravis-Activities of Daily Living (MG-ADL) Response at Day 43 | Placebo | 28.4 | percentage of participants | ||
| Percentage of Participants Achieving Myasthenia Gravis-Activities of Daily Living (MG-ADL) Response at Day 43 | Rozanolixizumab ~7 mg/kg | 68.2 | percentage of participants | ||
| Percentage of Participants Achieving Myasthenia Gravis-Activities of Daily Living (MG-ADL) Response at Day 43 | Rozanolixizumab ~10 mg/kg | 61.2 | percentage of participants | ||
| Change From Baseline to Day 43 in Myasthenia Gravis-Composite (MG-C) Total Score | Placebo | -2.029 | Standard Error 0.917 | units on a scale | |
| Change From Baseline to Day 43 in Myasthenia Gravis-Composite (MG-C) Total Score | Rozanolixizumab ~7 mg/kg | -5.930 | Standard Error 0.916 | units on a scale | |
| Change From Baseline to Day 43 in Myasthenia Gravis-Composite (MG-C) Total Score | Rozanolixizumab ~10 mg/kg | -7.554 | Standard Error 0.934 | units on a scale | |
| Change From Baseline to Day 43 in Quantitative Myasthenia Gravis (QMG) Total Score | Placebo | -1.915 | Standard Error 0.682 | units on a scale | |
| Change From Baseline to Day 43 in Quantitative Myasthenia Gravis (QMG) Total Score | Rozanolixizumab ~7 mg/kg | -5.398 | Standard Error 0.679 | units on a scale | |
| Change From Baseline to Day 43 in Quantitative Myasthenia Gravis (QMG) Total Score | Rozanolixizumab ~10 mg/kg | -6.672 | Standard Error 0.692 | units on a scale | |
| Change From Baseline to Day 43 in the Myasthenia Gravis (MG) Symptoms Patient Reported Outcome (PRO) 'Muscle Weakness Fatigability' Score | Placebo | -10.588 | Standard Error 3.034 | units on a scale | |
| Change From Baseline to Day 43 in the Myasthenia Gravis (MG) Symptoms Patient Reported Outcome (PRO) 'Muscle Weakness Fatigability' Score | Rozanolixizumab ~7 mg/kg | -23.029 | Standard Error 3.034 | units on a scale | |
| Change From Baseline to Day 43 in the Myasthenia Gravis (MG) Symptoms Patient Reported Outcome (PRO) 'Muscle Weakness Fatigability' Score | Rozanolixizumab ~10 mg/kg | -25.751 | Standard Error 3.095 | units on a scale | |
| Change From Baseline to Day 43 in the Myasthenia Gravis (MG) Symptoms Patient Reported Outcome (PRO) 'Physical Fatigue' Score | Placebo | -10.637 | Standard Error 3.051 | units on a scale | |
| Change From Baseline to Day 43 in the Myasthenia Gravis (MG) Symptoms Patient Reported Outcome (PRO) 'Physical Fatigue' Score | Rozanolixizumab ~7 mg/kg | -19.287 | Standard Error 3.046 | units on a scale | |
| Change From Baseline to Day 43 in the Myasthenia Gravis (MG) Symptoms Patient Reported Outcome (PRO) 'Physical Fatigue' Score | Rozanolixizumab ~10 mg/kg | -25.459 | Standard Error 3.107 | units on a scale | |
| Change From Baseline to Day 43 in the Myasthenia Gravis (MG) Symptoms Patient Reported Outcome (PRO) 'Bulbar Symptoms' Score | Placebo | -3.519 | Standard Error 2.397 | units on a scale | |
| Change From Baseline to Day 43 in the Myasthenia Gravis (MG) Symptoms Patient Reported Outcome (PRO) 'Bulbar Symptoms' Score | Rozanolixizumab ~7 mg/kg | -14.839 | Standard Error 2.406 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03971422/results